There were strong results to start the week from a provider of mobile payment services and a manufacturer of infection prevention products covered here. The valuation of one looks distinctly more appealing to us, but both have significant potential with huge addressable markets.
Tristel: strong results but caution
Tristel (LON: TSTL), the manufacturer of infection prevention and contamination control products, announced excellent interim results for the six months ending 31 December 2020.
Revenue rose 15% to £16.8m, of which overseas sales were up 20% to £10m and represented 60% of total sales. While sales in China grew 33%, they remain very small at only £0.8m suggesting plenty of potential in such a vast market. Growth in the UK was a…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login
Previous article
Next article
More on Directa Plus PLC
09/11/2021 · Company Insights
Graphene was hailed as a wonder material when it was first isolated in 2004, but the…
29/07/2021 · Company Insights
An impressive trading update encourages greater interest in a motor retailer covered here, but shareholders are at…
More on Fonix
22/07/2025 · Company Insights
This fast growing mobile payments specialist has issued another encouraging trading update, although the market was disappointed. It…
20/11/2024 · Company Insights
A software provider whose results we assess here continues to recover from the consequences of a…
More on Future
17/05/2024 · Company Insights
It’s all about the free cash flow for several companies covered here, although in…
07/04/2024 · Podcasts
In this week's episode of the Investor’s Champion Podcast Chris and Lee run key news affecting…
More on Tristel
30/07/2025 · Company Insights
Our coverage here includes a review of stunning results from a manufacturer of products for the…
14/05/2025 · Company Insights
News covered here includes our assessment of pleasing results from a specialist fishing tackle retailer, although…
More Company Insights
An elderly company knocks the lights out
Big buying from Fevertree Director following results
Excellent results elicit little response – time to buy?
More on Directa Plus PLC
More on Fonix
More on Future
More on Tristel
More Company Insights